- $681.67m
- $951.57m
- $893.40m
- 86
- 83
- 34
- 76
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 14.62 | ||
PEG Ratio (f) | 1.81 | ||
EPS Growth (f) | 8.76% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.2 | ||
Price to Tang. Book | 2.66 | ||
Price to Free Cashflow | 7.04 | ||
Price to Sales | 0.78 | ||
EV to EBITDA | 11.09 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 4.75% | ||
Return on Equity | 8.09% | ||
Operating Margin | 5.91% |
Financial Summary
Year End 29th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 780.6 | 738.3 | 818.1 | 859.4 | 893.4 | 853.02 | 888.4 | 2.93% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -32.44 | n/a | n/a | +76.6 | +48.14 | -16.85 | +31.24 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Varex Imaging Corporation is a designer and manufacturer of X-ray tubes, digital detectors and other image processing solutions. The Company operates through two segments: Medical and Industrial. The Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, digital detectors, ionization chambers and buckys, high voltage connectors, image-processing software and workstations, three-dimensional (3D) reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. These components are used in a range of medical imaging applications. The Industrial segment designs, develops, manufactures, sells and services X-ray imaging products for use in a number of markets, including security applications for cargo screening at ports and borders and baggage screening at airports, and nondestructive testing, irradiation and inspection applications used in various other markets.
Directors
- Ruediger Naumann-Etienne NEC (75)
- Sunny Sanyal PRE (57)
- Shubham Maheshwari CFO (50)
- Kimberley Honeysett SVP (50)
- Brian Giambattista SVP (62)
- Mark Jonaitis SVP (60)
- Andrew Hartmann SVP (59)
- Jocelyn Chertoff IND (66)
- Timothy Guertin IND (72)
- Jay Kunkel IND (62)
- Walter Rosebrough IND (67)
- Christine Tsingos IND (63)
- Last Annual
- September 29th, 2023
- Last Interim
- December 29th, 2023
- Incorporated
- July 18th, 2016
- Public Since
- January 20th, 2017
- No. of Shareholders
- 1,310
- No. of Employees
- 2,300
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 40,600,000
- Address
- 1678 S Pioneer Rd, SALT LAKE CITY, 84104-4205
- Web
- https://www.vareximaging.com/
- Phone
- +1 8019725000
- Contact
- Christopher Belfiore
- Auditors
- Deloitte & Touche LLP
Upcoming Events for VREX
Q2 2024 Varex Imaging Corp Earnings Release
Q3 2024 Varex Imaging Corp Earnings Release
Similar to VREX
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 19:22 UTC, shares in Varex Imaging are trading at $16.79. This share price information is delayed by 15 minutes.
Shares in Varex Imaging last closed at $16.79 and the price had moved by -5.41% over the past 365 days. In terms of relative price strength the Varex Imaging share price has underperformed the S&P500 Index by -22.67% over the past year.
The overall consensus recommendation for Varex Imaging is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Varex Imaging does not currently pay a dividend.
Varex Imaging does not currently pay a dividend.
Varex Imaging does not currently pay a dividend.
To buy shares in Varex Imaging you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $16.79, shares in Varex Imaging had a market capitalisation of $681.67m.
Here are the trading details for Varex Imaging:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: VREX
Based on an overall assessment of its quality, value and momentum Varex Imaging is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Varex Imaging is $27.88. That is 66.05% above the last closing price of $16.79.
Analysts covering Varex Imaging currently have a consensus Earnings Per Share (EPS) forecast of $0.97 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Varex Imaging. Over the past six months, its share price has underperformed the S&P500 Index by -20.71%.
As of the last closing price of $16.79, shares in Varex Imaging were trading -12.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Varex Imaging PE ratio based on its reported earnings over the past 12 months is 14.62. The shares last closed at $16.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Varex Imaging's management team is headed by:
- Ruediger Naumann-Etienne - NEC
- Sunny Sanyal - PRE
- Shubham Maheshwari - CFO
- Kimberley Honeysett - SVP
- Brian Giambattista - SVP
- Mark Jonaitis - SVP
- Andrew Hartmann - SVP
- Jocelyn Chertoff - IND
- Timothy Guertin - IND
- Jay Kunkel - IND
- Walter Rosebrough - IND
- Christine Tsingos - IND